Fulcrum Therapeutics is a startup based in the United States, 1 tracked investor.
Fulcrum Therapeutics is a company headquartered in the United States. Brouky records 1 investor associated with the company.
Fulcrum Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule therapeutics that modulate gene expression to treat genetically defined rare diseases. Its lead clinical program is pociredir, aimed at addressing the root causes of gene mis-expression in relevant patient populations.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.